Patients with hidradenitis suppurativa have a high prevalence of acne vulgaris, according to the latest research.
Superficial and medium depth peels could be effective treatment options for patients with mild to moderate acne, says a recent review.
The past decade has seen significant advances in the understanding of molecular pathogenesis of skin cancer leading to the development of targeted treatments and immunotherapies that have dramatically improved progression free survival and even overall survival in melanoma, basal cell carcinoma (BCC) and even some rarer cutaneous carcinomas.
A recent study suggests that genes such as ERBB2, KIT, FGFR3, and RET might be relevant in the treatment of individual patients with cutaneous melanoma.
Cell-free circulating DNA (cfDNA) can provide a useful snapshot of the BRAF and NRAS genotype of melanoma patients’ tumor tissue and act as a useful surrogate to assessing tissue biopsies for the markers, a recent study suggests.
IDO inhibitors have recently emerged as a new and exciting class of anticancer drugs. Learn more about this and other immunotherapy treatments in this article.
Role of retinoids in acne set to be cemented further with advent of first fourth generation product.
Combined plant-based therapy is more effective for treating mild-to-moderate acne than a synthetic antibiotic
Combining antibody IgG2a with a TNF protein shows promise against melanoma in mouse studies.
Doctors suggest that cytokine antagonists may lessen the severity of the rash.